Commentary on the MID3 Good Practices Paper

During the last 10 years the European Medicines Agency (EMA) organized a number of workshops on modeling and simulation, working towards greater integration of modeling and simulation (M&S) in the development and regulatory assessment of medicines. In the 2011 EMA – European Federation of Pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Manolis, Efthymios, Brogren, Jacob, Cole, Susan, Hay, Justin L., Nordmark, Anna, Karlsson, Kristin E., Lentz, Frederike, Benda, Norbert, Wangorsch, Gaby, Pons, Gerard, Zhao, Wei, Gigante, Valeria, Serone, Francesca, Standing, Joseph F., Dokoumetzidis, Aris, Vakkilainen, Juha, van den Heuvel, Michiel, Mangas Sanjuan, Victor, Taminiau, Johannes, Kerwash, Essam, Khan, David, Musuamba, Flora Tshinanu, Skottheim Rusten, Ine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529732/
https://www.ncbi.nlm.nih.gov/pubmed/28653481
http://dx.doi.org/10.1002/psp4.12223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529732/
https://www.ncbi.nlm.nih.gov/pubmed/28653481
http://dx.doi.org/10.1002/psp4.12223

Ejemplares similares